Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987844 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation
A Phase 3 study of Chronic Constipation, sponsored by Movetis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,775
- Enrollment target
- 1
- Study location
NCT00987844: Completed Phase 3 study of Chronic Constipation, sponsored by Movetis.
NCT00987844 is a Phase 3 study of Chronic Constipation that has completed, run by Movetis. The registered enrollment target is 1,775 participants, above the 349-participant average among 4 other Chronic Constipation trials with a reported enrollment target (409% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00987844, a Phase 3 study of Chronic Constipation, has completed, sponsored by Movetis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,775 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: To evaluate the clinical long-term safety and the tolerability, patient satisfaction, pharmacokinetics and use of pattern of prucalopride given in doses up to 4 mg per day to patients with chronic constipation (CC).
Conditions Studied
Interventions
- DRUG Prucalopride
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,775 participants |
| Start Date | 1998-07 |
| Phase | Phase 3 |
What the finished NCT00987844 record still lists
NCT00987844 is an interventional study that assigns participants to a tested intervention. Its 1,775 participants enrollment target places it among the larger protocols in the corpus, above the 349-participant average among 4 other Chronic Constipation trials with a reported enrollment target (409% higher).
The record links to 1 condition, with Chronic Constipation appearing as the primary indexed condition, and to 1 intervention - of which Prucalopride is the first listed.
NCT00987844 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00987844 about?
NCT00987844 is a clinical study titled "Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation". Objectives: To evaluate the clinical long-term safety and the tolerability, patient satisfaction, pharmacokinetics and use of pattern of prucalopride given in doses up to 4 mg per day to patients with chronic constipation (CC).
What is the current status of trial NCT00987844?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,775 participants. The study started on 1998-07.
What conditions does trial NCT00987844 study?
This clinical trial studies the following conditions: Chronic Constipation.
What interventions are being tested in trial NCT00987844?
The interventions under investigation include: Prucalopride (DRUG).
Who is sponsoring clinical trial NCT00987844?
This trial is sponsored by Movetis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00987844 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
COMPLETED · Phase 3
-
Trial of Linaclotide in Patients With Chronic Constipation
COMPLETED · Phase 3
-
Perineal Self-Acupressure
COMPLETED · NA
-
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia